NDC properties for "Pradaxa 150 MG Oral Pellet" (RxCUI 2590621)
About this data
The tables show NDC propoerties for Pradaxa 150 MG Oral Pellet with the RxCUI 2590621
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Pradaxa 150 MG Oral Pellet (RxCUI 2590621)
| MMSL_CODE | BD39050 |
|---|---|
| NDA | NDA214358 |
| RxCUI | 2590621 |
| SPL_SET_ID | 9ac0a64a-8666-45f7-9d4f-40fd894f7e6d |
| Prescribable Synonym | Pradaxa 150 MG Oral Pellet |
| RXNAV_STR | Pradaxa 150 MG Oral Pellet |
| RxNorm Name | dabigatran etexilate 150 MG Oral Pellet [Pradaxa] |
| RxNorm Synonym | Pradaxa 150 MG Oral Pellet |
| Related queries | Interactions (for RxCUI 2590621) |
NDC Properties
NDC Item 00597045016
| NDC 9 | 0597-0450 |
|---|---|
| NDC 10 | 0597-0450-16 |
| NDC Item | 00597045016 |
| Packaging | 1 BAG in 1 CARTON (0597-0450-16) / 60 PELLET in 1 BAG |
| COLORTEXT | YELLOW(yellow-white) |
| Color | C48330 __ |
| FDA SPL set id | 749356 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2022-03-16 |
| Marketing status | ACTIVE |
| NDA | NDA214358 |
| Related queries | Properties for NDC 9 0597-0450 |